Asset profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructu…
Newest first.
| Registry ID | Phase | Status | Primary completion | Enrollment | Sites |
|---|---|---|---|---|---|
| NCT07816315 | Phase 3 | Not yet recruiting | Dec 15, 2028 | 500 | |
| NCT07841899 | Phase 3 | Not yet recruiting | Dec 15, 2028 | 450 | |
| NCT07816289 | Phase 3 | Not yet recruiting | Dec 15, 2028 | 400 | |
| NCT07842016 | Phase 3 | Not yet recruiting | Dec 15, 2028 | 450 |
Other drugs and candidates from the same company tracked in this sector.